Richard Gless Selected Research

Atherosclerosis

9/2009

Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Gless Research Topics

Disease

2	Hypertension (High Blood Pressure) 03/2012 - 02/2011
1	Type 2 Diabetes Mellitus (MODY) 03/2012
1	Insulin Resistance 02/2011
1	Obesity 02/2011
1	Vascular Remodeling 09/2009
1	Abdominal Aortic Aneurysm 09/2009
1	Dyslipidemias (Dyslipidemia) 09/2009
1	Atherosclerosis 09/2009

Drug/Important Bio-Agent (IBA)

3	Epoxide HydrolasesIBA 03/2012 - 09/2009
2	1- (1- acetyl- piperidine- 4- yl)- 3- adamantan- 1- yl- ureaIBA 03/2012 - 02/2011
2	Angiotensin IIIBA 02/2011 - 09/2009
1	Glucose (Dextrose)FDA LinkGeneric 02/2011
1	ApolipoproteinsIBA 09/2009

Therapy/Procedure

1	Ligation 09/2009